产品名称：1,2-二棕榈油酰基-sn-甘油-3-磷酸胆碱
英文名称：1,2-dipalmitelaidoyl-sn-glycero-3-phosphocholine
别名：16:1 (Δ9-Trans) PC
英文别名：1,2-di-(9E-hexadecenoyl)-sn-glycero-3-phosphocholine；PC(16:1(9E)/16:1(9E))
规格或纯度：>99%
运输条件：超低温冰袋运输
生化机理
Phosphatidylcholine (PC) helps to inhibit the penetrance of bacteria.
CAS编号：56816-00-3
储存温度
-20°C储存
分子量：730.007
分子式：C40H76NO8P
Product Introduction16:1 (Δ9-Trans) PC (1,2-dipalmitelaidoyl-sn-glycero-3-phosphocholine) is a lipid derivative which has two 16 carbon fatty acid chains, each having one trans double bond at 9th carbon.The list of Phosphatidylcholine products offered by Avanti is designed to provide compounds having a variety of physical properties. Products available include short chain (C3-C8 are water soluble and hygroscopic), saturated, multi-unsaturated and mixed acid PC′s. All of the products are purified by HPLC, and special precautions are taken to protect the products for oxidization and hydrolysis.Application16:1 (Δ9-Trans) PC (1,2-dipalmitelaidoyl-sn-glycero-3-phosphocholine) may be used in liposomes to study the cell proliferation of several cell lines and as a neutral or helper lipid to prepare liposomes
Product Introduction16:1 (Δ9-Trans) PC (1,2-dipalmitelaidoyl-sn-glycero-3-phosphocholine) is a lipid derivative which has two 16 carbon fatty acid chains, each having one trans double bond at 9th carbon.The list of Phosphatidylcholine products offered by Avanti is designed to provide compounds having a variety of physical properties. Products available include short chain (C3-C8 are water soluble and hygroscopic), saturated, multi-unsaturated and mixed acid PC′s. All of the products are purified by HPLC, and special precautions are taken to protect the products for oxidization and hydrolysis.Application16:1 (Δ9-Trans) PC (1,2-dipalmitelaidoyl-sn-glycero-3-phosphocholine) may be used in liposomes to study the cell proliferation of several cell lines and as a neutral or helper lipid to prepare liposomes
德尔塔生物的产品主要服务于药物靶标发现，先导化合物发现、合成及优化，药物候选化合物发现等新药研发的关键环节。以药物构效和构性关系、药物化合物逆合成分析等理论为指导，公司多年密切跟踪药物化合物的动态，形成以药物分子砌块研发设计、定制化合成、分子结构确证、纯度检测及纯化等为代表的核心技术体系，构筑起种类全、规模大的药物分子砌块产品库，能够满足客户对药物分子砌块的高技术、多品类、微小剂量及多频次需求。
德尔塔生物致力于成为全球药物分子砌块领域的领先企业，实现紧跟医药前沿研发方向，及时开发出结构独特、功能多样的药物分子的类型，快速响应客户对药物分子砌块和科学试剂的多样化需求，助力全球新药研发机构加速新药研发进程或降低新药研发成本。